Market Place
Sourcing Support
Recipharm strengthens pharmaceutical development capabilities
03 Oct 2024 //
PRESS RELEASE
LenioBio collaborates with ReciBioPharm to scale ALiCE Technology
02 Oct 2024 //
PRESS RELEASE
Recipharm and Exela announce exclusive strategic alliance
02 Oct 2024 //
PRESS RELEASE
Blue Wolf Capital to Create New CDMO Platform
25 Sep 2024 //
BUSINESSWIRE
Recipharm Launches New Platform, ReciPredict
04 Sep 2024 //
CONTRACT PHARMA
MARBIO receives new grant funding
13 Jun 2024 //
PRESS RELEASE
Recipharm strengthens its competitiveness by focusing on leading, core CDMO
03 Apr 2024 //
FIERCE PHARMA
Bespak Confirms Completion of Separation From Recipharm
02 Apr 2024 //
ACCESSWIRE
Blue Wolf Capital to Acquire OSD CDMO Sites from Recipharm
02 Apr 2024 //
BUSINESSWIRE
Recipharm attains major sustainability milestones
26 Mar 2024 //
PRESS RELEASE
ReciBioPharm GeneVentiv Partner For AAV Gene Therapy In Hemophilia
13 Mar 2024 //
PRESS RELEASE
Recipharm harmonizes its global quality operations with Veeva Vault Quality
19 Dec 2023 //
PRESS RELEASE
Recipharm to change CEOs, spin out inhaler business
22 Nov 2023 //
ENDPTS
Recipharm CEO anticipates 2024 will be ‘as hard’ for CDMOs
12 Oct 2023 //
ENDPTS
Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy
05 Sep 2023 //
PRESS RELEASE
Recipharm and Honeywell to speed development of inhalers with a near-zero global warming potential propellant
17 Aug 2023 //
PRESS RELEASE
Honeywell, Recipharm Partner on pMDIs with Near-zero GWP Propellant
17 Aug 2023 //
CONTRACT PHARMA
Recipharm Expands Testing Capabilities
13 Jul 2023 //
CONTRACT PHARMA
Statement from Arranta Bio on settlement of Thermo Fisher litigation
05 Jun 2023 //
PRESS RELEASE
Recipharm makes senior appointment to head up biologics business unit, ReciBioPharm
04 May 2023 //
PRESS RELEASE
FDA Approves Recipharm Site for Manufacture of VOWST
02 May 2023 //
CONTRACT PHARMA
Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics
28 Apr 2023 //
PRESS RELEASE
Recipharm Names Joaquim Mascaro CFO
05 Apr 2023 //
CONTRACT PHARMA
Stevanato Group Collaborates with Recipharm to Develop Pre-fillable Syringes
16 Mar 2023 //
BUSINESSWIRE
Recipharm`s Arranta Bio expands RNA process development capacity
09 Mar 2023 //
PRESS RELEASE
FDA Issues Form 483 to Recipharm Monts
23 Dec 2022 //
FDA
Recipharm Invests in Single Dose Nasal Platform Capabilities
30 Nov 2022 //
CONTRACTPHARMA
Recipharm Strengthens Pre-filled Syringe and Cartridge Offering
02 Nov 2022 //
CONTRACTPHARMA
Recipharm Invests in Lab+ Technology at Kaysersberg Facility
26 Oct 2022 //
CONTRACTPHARMA
Recipharm to Add High-Speed Filling Line to Wasserburg Facility
22 Oct 2022 //
PHARMTECH
Transpire Bio Inks Second Agreement with Recipharm
29 Sep 2022 //
CONTRACTPHARMA
Recipharm steps up to support inhaled asthma, COPD treatments
19 Jul 2022 //
FIERCEPHARMA
Transpire Bio announces agreement with Recipharm for inhaled medicine
15 Jul 2022 //
MANUFACTURINGCHEMIST
Recipharm offers services to enable switch to next generation pMDI propellants
29 Apr 2022 //
PRESS RELEASE
Recipharm completes US biologics acquisitions
11 Apr 2022 //
PRESS RELEASE
Recipharm pledges support to conflict victims
10 Mar 2022 //
PRESS RELEASE
Recipharm Strengthens Aseptic Processing Capabilities
24 Feb 2022 //
CONTRACTPHARMA
Swedish CDMO Recipharm is absording Arranta Bio and Vibalogics
19 Feb 2022 //
FIERCEPHARMA
Recipharm`s global deal spree continues with acquisition of Portuguese CDMO
02 Feb 2022 //
ENDPTS
Construction works launch at new fill finish facility in Morocco
28 Jan 2022 //
PRESS RELEASE
Recipharm secures vaccine manufacturing deal
27 Jan 2022 //
PRESS RELEASE
Recipharm Sells Fontaine-lès-Dijon site to Astrea
12 Jan 2022 //
CONTRACTPHARMA
After a year of big investments, Recipharm sells off assets in Europe
11 Jan 2022 //
PRESS RELEASE
Pharmaron Acquires Commercial API Manufacturing Facility in UK
09 Jan 2022 //
BUSINESSWIRE
First Customer Boards Recipharm’s Soft Mist Inhaler Technology Platform
24 Sep 2021 //
CONTRACTPHARMA
Recipharm Expands Analytical Services Capabilities
26 Aug 2021 //
CONTRACTPHARMA
Recipharm`s CDMO footprint grows with facility in India
24 Jul 2021 //
FIERCEPHARMA
Recipharm Invests in Fill Finish Capacity
15 Jul 2021 //
CONTRACT PHARMA
Moroccan government drops $500M into new Recipharm fill-finish plant
07 Jul 2021 //
ENDPTS
Recipharm sets sights on fill-finish plant in Africa
06 Jul 2021 //
FIERCEPHARMA
Recipharm Bolsters Biologics Offering
11 Feb 2021 //
CONTRACTPHARMA
Roar BidCo has received competition clearance from the EU Commission
11 Feb 2021 //
PRNEWSWIRE
French API maker Seqens primed for sale to the tune of $2.4B: report
11 Feb 2021 //
FIERCE PHARMA
Recipharm bolsters biologics offering
10 Feb 2021 //
PRESS RELEASE
Recipharm and Medspray Complete Joint Venture
08 Feb 2021 //
CONTRACT PHARMA
